Labcorp Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Labcorp Holdings şirketinin toplam hissedar öz sermayesi $8.2B ve toplam borcu $6.8B olup, bu da borç-öz sermaye oranını 83.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $18.6B ve $10.4B dir. Labcorp Holdings 'in FAVÖK'ü $1.1B faiz karşılama oranı 6.2 dur. Şirketin $1.5B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

83.2%

Borç/özkaynak oranı

US$6.81b

Borç

Faiz karşılama oranı6.2x
NakitUS$1.52b
EşitlikUS$8.19b
Toplam yükümlülüklerUS$10.43b
Toplam varlıklarUS$18.61b

Son finansal sağlık güncellemeleri

Recent updates

Is Labcorp Holdings (NYSE:LH) Using Too Much Debt?

Oct 19
Is Labcorp Holdings (NYSE:LH) Using Too Much Debt?

When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Sep 12
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Laboratory Corporation: Difficult To Eye Long-Term Compounding Ability

Sep 11

Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)

Jul 20
Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)

Laboratory Corporation: Limited Upside Visibility, Reiterate Hold

Jun 21

When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Jun 13
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year

May 08
Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year

Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72

Apr 30
Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72

Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72

Apr 15
Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72

Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark

Apr 06
Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark

Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear

Apr 01

Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72

Feb 25
Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72

We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings

Feb 22
We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings

An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued

Feb 21
An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued

Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72

Jan 31
Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72

Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly

Jan 30
Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly

Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72

Jan 15
Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72

Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio

Jan 05
Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio

Laboratory Corporation: Multiple Updates, Same Investment Conclusion

Dec 02

Laboratory Corp.: Rate On Capital Deployed Contracting, Hold

Sep 14

Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea

Jul 05

Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts

Jul 04
Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts

Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?

Jun 23
Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?

Laboratory Corporation: Predictability Of Cash Flows Less Visible

Jun 21

Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

May 26
Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher

Mar 16
Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher

Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate

Mar 02
Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: LH 'nin kısa vadeli varlıkları ( $4.9B ) kısa vadeli yükümlülüklerini ( $3.4B ) aşıyor.

Uzun Vadeli Yükümlülükler: LH 'un kısa vadeli varlıkları ( $4.9B ) uzun vadeli yükümlülüklerini ( $7.0B ) karşılamamaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: LH 'nin net borç/öz sermaye oranı ( 64.6% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: LH 'nin borç/öz sermaye oranı son 5 yılda 91.1% seviyesinden 83.2% seviyesine düştü.

Borç Kapsamı: LH 'nin borcu işletme nakit akışı ( 20.4% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: LH 'in borcuna ilişkin faiz ödemeleri EBIT ( 6.2 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.


Bilanço


Sağlıklı şirketleri keşfedin